Related Experiment Video
Updated: Mar 21, 2026

Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis
Published on: July 11, 2014
Plasma Lipidomics Investigation of Hemodialysis Effects by Using Liquid Chromatography-Mass Spectrometry
Lichao Wang1,2, Chunxiu Hu2, Shuxin Liu3
1College of Chemical Engineering, Zhejiang University of Technology , Hangzhou 310014, China.
Insights
Chronic kidney disease (CKD) patients undergoing hemodialysis (HD) exhibit significant alterations in lipid metabolism. Hemodialysis impacts levels of free fatty acids and other lipids, offering insights into uremia-related complications.
Area of Science:
- Biochemistry
- Metabolomics
- Nephrology
Background:
- Chronic kidney disease (CKD) is a global health issue, often progressing to uremia.
- Hemodialysis (HD) is a primary treatment for uremia, but patients face complications like lipid disorders.
Purpose of the Study:
- To investigate the effects of hemodialysis on lipid metabolism in uremic patients.
- To utilize lipidomics to understand complex complications in HD patients.
Main Methods:
- Employed ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UPLC-Q-TOF/MS) based lipidomics.
- Analyzed 87 human plasma samples from pre-hemodialysis (pre-HD), post-hemodialysis (post-HD), and healthy control groups.
Main Results:
- Significant changes in plasma lipid profiles were observed in HD patients compared to controls (p < 0.05).
- Levels of free fatty acids (FFA), saturated FFA, eicosanoids, lyso-phosphatidylinositols, and lyso-phosphatidylethanolamines were elevated pre-HD but decreased post-HD.
- Specific ratios like FFA 16:1/FFA 16:0 and FFA 18:1/FFA 18:0 also showed significant changes.
Conclusions:
- UPLC-Q-TOF/MS lipidomics is a valuable tool for studying uremia-related lipid alterations.
- Findings contribute to understanding the complex complications associated with hemodialysis therapy.
Abstract:
Chronic kidney disease (CKD) has been a global health problem that has a great possibility of being developed into uremia in the end. Hemodialysis (HD) is the most commonly used strategy for treating uremic patients; however, the patients still have a high risk of suffering various complications. It is well recognized that lipid disorder usually occurs in maintenance HD patients. To systemically study the effects of HD on lipid metabolism associated with uremia, we employed an ultraperformance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UPLC-Q-TOF/MS)-based lipidomics method. A total of 87 human plasma samples from patients with prehemodialysis (pre-HD)/posthemodialysis (post-HD) treatment and the healthy controls were enrolled in the study. As compared with pre-HD patients, many plasma lipids showed significant changes (p < 0.05) in patients receiving HD therapy. Specifically, sum of free fatty acids (FFA) as well as saturated FFA and eicosanoids and sums of lyso-phosphatidylinositols and lyso-phosphatidylethanolamines, FFA 16:1/FFA 16:0, and FFA 18:1/FFA 18:0 were obviously higher in the pre-HD group than in the controls while they were significantly lower in patients after HD. These results indicated that UPLC-Q-TOF/MS-based lipidomics is a promising approach to investigate lipid alterations in relation to uremia and it is helpful to understand complex complications involved in HD patients.
Related Concept Videos
Dialysis
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications

